Skip to main content
Signal Transduction and Targeted Therapy logoLink to Signal Transduction and Targeted Therapy
. 2023 May 5;8:181. doi: 10.1038/s41392-023-01475-8

Retraction Note: Dickkopf-1 contributes to hepatocellular carcinoma tumorigenesis by activating the Wnt/β-catenin signaling pathway

Rui Zhang 1,2, Hao-Ming Lin 1, Ruth Broering 2, Xiang-de Shi 1, Xian-huan Yu 1, Lei-bo Xu 1, Wen-rui Wu 1,, Chao Liu 1,
PMCID: PMC10162956  PMID: 37147281

Retraction to: Signal Transduction and Targeted Therapy 10.1038/s41392-019-0082-5, published online 06 December 2019

The authors have retracted this article. After publication, concerns were raised regarding suspected overlap in the cell images in Figs. 2 and 3. Specifically:

  • Figs. 2f and 3f (HUH-7 Scramble) appear to contain an overlapping area.

  • HepG2 Scramble in Fig. 2d and HUH-7 LV-DKK1 in Fig. 3d appear to be mirror images.

  • A part of the HUH7 Scramble image in Fig. 2d appears to be enlarged and presented as HepG2 Scramble.

  • The authors therefore no longer have confidence in the presented data.

All authors agree to this retraction.

Contributor Information

Wen-rui Wu, Email: doctorrui@126.com.

Chao Liu, Email: mdliuchao@hotmail.com.


Articles from Signal Transduction and Targeted Therapy are provided here courtesy of Nature Publishing Group

RESOURCES